Pudendal Nerve Block for Hemorrhoidectomy

Francesco Mongelli

Status: Completed

Conditions: Postoperative Pain; Hemorrhoids

Treatments: Procedure: Local anesthetic (ropivacaine)

Study type: Interventional

Funder types: Other

Identifiers

NCT04251884

CE TI 3222

Details and patient eligibility

About

Patients undergoing Milligan-Morgan hemorrhoidectomy will be randomized to receive or not the pudendal nerve block after the spinal anesthesia.

Full description

Patients included were those undergoing Milligan-Morgan hemorrhoidectomy under spinal anaesthesia from January 2018 to December 2019. Exclusion criteria were age < 18 years old, pregnancy and allergy to local anaesthetics. Patients meeting inclusion and exclusion criteria were randomized to undergo an ultrasound-guided pudendal nerve block. Per-protocol all patients received postoperative metronidazole 500 mg for 3 days, laxative, a basis analgesia with NSAID and opioids as needed. Postoperative pain on the visual analogue scale (VAS) at 6, 12, 24 and 48 hours, opioids needed, complications and length of hospital stay were recorded. Patients and ward personnel were not informed about the treatment arm. All Patients were further controlled 6 weeks after the intervention.

Enrollment: 49 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients affected by haemorrhoids (grade III and IV) and treated with Milligan-Morgan hemorrhoidectomy under spinal anaesthesia
• Signed informed consent

Exclusion criteria

• Age < 18 years old
• Pregnancy
• Allergy to local anaesthetics

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

49 participants in 2 patient groups

Receiving the pudendal nerve block

Experimental group

Treatment:

Procedure: Local anesthetic (ropivacaine)

Not receiving the pudendal nerve block

Active Comparator group

Treatment:

Procedure: Local anesthetic (ropivacaine)